Factors affecting community pharmacists' participation in a Pharmaceutical care service for asthmatic patients;Factores que influyen en la participación de farmacéuticos comunitarios en un servicio de atención farmacéutica para pacientes asmáticos

Pharmaceutical Care Espana

Volumn 14, Issue 1, 2012, Pages 19-27

  Garcia Cardenas V ^a   Gastelurrutia, M A ^a   Benrimoj, S I ^b   Martinez Martinez F ^a   Faus, M J ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Asthma; Community pharmacy; Interview; Observation; PRECEDE

Indexed keywords

ARTICLE; ASTHMA; CLINICAL ASSESSMENT; HEALTH SERVICE; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL EDUCATION; MEDICAL FEE; PARTICIPATION; PATIENT COUNSELING; PERSONNEL MANAGEMENT; PHARMACEUTICAL CARE; PHARMACIST; PHARMACIST ATTITUDE; PHARMACY; PUBLIC-PRIVATE PARTNERSHIP; SATISFACTION; SEMI STRUCTURED INTERVIEW;

EID: 84860349849     PISSN: None     EISSN: 11396202     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Encuesta Europea de Salud en España [Acceso 12/08/2011]. Disponible en: http://www.ine.es/jaxi/tabla.do?path=/t15/p420/a2009/p01/l0/&file= 02013.px&type=pcaxis&L=0
2. Rabe KF, Vermiere PA, Soriano JB, Maier WC. Clinical management of asthma in 1999; the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000; 16: 802-807. (Pubitemid 32049363)
3. López Viña A, Cimas JE, Díaz Sánchez C, Coria G, Vegazo O, Picado C. A comparison of primary care physicians and pneumologist in the management of asthma in Spain: ASES study. Respir Med. 2003; 97: 872-881.
4. López Viña A. Actitudes para fomentar el cumplimiento terapéutico en el asma. Arch Bronconeumol. 2005; 41: 334-340. (Pubitemid 41020580)
5. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol. 2004; 4: 191-195. (Pubitemid 38685520)
6. Corsico AG, Cazzoletti L, De Marco R, Janson C, Jarvis D, Zoia MC, et al. Factors affecting adherence to asthma treatment in an international cohort of young and middle-aged adults. Respir Med. 2007; 101: 1.363-1.367.
7. Cochrane GM, Horne R, Chanez I. Compliance in asthma. Respir Med CME. 1999; 93: 763-769.
8. Paasche-Orlow MK, Riekert KA, Bilderback A, Chanmugam A, Hill P, Rand CS, et al. Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med. 2005; 172: 980-986.
9. López Viña A. Attitude Changes Needed to Foster Treatment Adherence in Patients With Asthma. Arch Bronconeumol. 2005; 41: 334-340. (Pubitemid 41020580)
10. Fitzgerald JM, Boulet LP, MvIvor RA, Zimmerman S, Chapman KR. Asthma control in Canada remains suboptimal: the reality of asthma control study. Can Resp J. 2006; 13: 253-259.
11. Sudre P, Jacquemet S, Uldry C, Perneger TV. Objectives, methods and content of patient education programmes for adults with asthma: systematic review of studies published between 1979 and 1998. Thorax. 1999; 54: 681-687. (Pubitemid 29341403)
12. Self TH, Nahata MC: improving outcomes in asthma: role of pharmacy. Ann Pharmacother. 1997; 31: 495-497. (Pubitemid 27155257)
13. National Heart, Lung, and Blood Institute National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. 2007 [Acceso 01/09/2011]. Disponible en: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf
14. García-Cárdenas V, Benrimoj SI, Faus MJ, Martínez-Martínez F. Efecto de una intervención farmacéutica sobre el grado de control del paciente asmático (AFasma): Diseño del estudio y caracterización de la muestra [Abstract]. Ars Pharm. 2011; 52 supl 1: 61.
15. Benrimoj SI, Feletto E, Gastelurrutia MA, Martínez-Martínez F, Faus Dáder MJ. Un enfoque holístico e integrado de la implantación de los servicios farmacéuticos cognitivos. Ars Pharm. 2010; 51: 69-88.
16. Benrimoj SI, Gastelurrutia MA, Farragher T, Feletto E, García-Delgado P, Sáez-Benito L, et al. Resultados de la primera fase del programa conSIGUE: Estudio piloto: medida del impacto clínico, económico y humanístico del seguimiento farmacoterapéutico en mayores polimedicados. Madrid: Ergon, 2010.
17. García-Cárdenas V, Feletto E, Fernández- Galdón RP, Navas-Vargas EM, Martínez-Martínez F, Benrimoj SI. Formación de formadores colegiales. Programa conSIGUE [Abstract]. Ars Pharm. 2009; 50 supl 1: 51-83.
18. Green LW, Kreuter MW, Deeds SG, Patridge KB. Health education planning: A diagnostic approach. Palo Alto: Mayfield, 1980.
19. Yeo M, Berzins S, Addington D. Development of an early psychosis public education program using the PRECEDE PROCEED model. Health Educ Res. 2007; 22: 639-647. (Pubitemid 47428951)
20. Chiang LC, Huang JL, Lu CM. Educational diagnosis of selfmanagement behaviours of parents with asthmatic children by triangulation based on PRECEDE-PROCEED model in Taiwan. Patient Educ Couns. 2003; 49: 19-25.
21. Bimbela JL, Gorrotxategi M. Herramientas para mejorar la adhesión terapéutica del paciente. El caso de la diabetes. Granada: Escuela Andaluza de Salud Pública, 2001.
22. Berg BC. Qualitative research methods for the social sciences. Boston: Allyn & Bacon, 1989.
23. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008; 42: 861-868. (Pubitemid 351778094)
24. Gastelurrutia MA, Benrimoj SI, Castrillon CC, De Amezua MJ, Fernández-Llimós F, Faus MJ. Facilitators for practice change in Spanish community pharmacy. Pharm World Sci. 2009; 31: 32-39.
25. Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia's community pharmacies: Australia's National Pharmacy Database Project. Int J Pharm Pract. 2007; 15: 185-191.
26. Van Mil F. Atención Farmacéutica en Farmacia Comunitaria en Europa, retos y barreras. Pharm Care Esp. 2000; 2: 42-56.
27. . Fang Y, Yang S, Feng B, Ni Y, Zhang K. Pharmacists' perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China. Health Soc Care Community. 2011; 19: 189-197.
28. Lounsbery JL, Green CG, Bennett MS, Pedersen CA. Evaluation of pharmacists' barriers to the implementation of medication therapy management services. J Am Pharm Assoc. 2009; 49: 51-58.
29. Blake KB, Madhavan SS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother. 2010; 44: 424-431.